ATE132748T1 - Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres - Google Patents

Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres

Info

Publication number
ATE132748T1
ATE132748T1 AT91102330T AT91102330T ATE132748T1 AT E132748 T1 ATE132748 T1 AT E132748T1 AT 91102330 T AT91102330 T AT 91102330T AT 91102330 T AT91102330 T AT 91102330T AT E132748 T1 ATE132748 T1 AT E132748T1
Authority
AT
Austria
Prior art keywords
inner ear
dihydropyridine
blood circulation
improve inner
ear blood
Prior art date
Application number
AT91102330T
Other languages
English (en)
Inventor
Mitsuyoshi Nakashima
Toshihiko Uematsu
Kazuo Umemura
Yutaka Kohno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE132748T1 publication Critical patent/ATE132748T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
AT91102330T 1990-02-21 1991-02-19 Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres ATE132748T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4041390 1990-02-21
JP12211090 1990-05-10

Publications (1)

Publication Number Publication Date
ATE132748T1 true ATE132748T1 (de) 1996-01-15

Family

ID=26379878

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91102330T ATE132748T1 (de) 1990-02-21 1991-02-19 Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres

Country Status (5)

Country Link
EP (1) EP0447812B1 (de)
KR (1) KR0178273B1 (de)
AT (1) ATE132748T1 (de)
CA (1) CA2036708A1 (de)
DE (1) DE69116187T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10025152A1 (de) * 2000-05-23 2001-12-06 Marlies Knipper Neurotrophin stimulierende Substanzen, insbesondere Thyroidhormon (T3) oder Schilddrüsenhormon stimulierende Substanzen, für die therapeutische Behandlung von lärm-und altersbedingter Schwerhörigkeit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323604B1 (de) * 1987-12-29 1994-05-11 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie
DE3888144T2 (de) * 1987-12-29 1994-06-23 Fujisawa Pharmaceutical Co Gehirn-Neuron schützendes Mittel, enthaltend eine Dihydropyridin-Verbindung.

Also Published As

Publication number Publication date
CA2036708A1 (en) 1991-08-22
EP0447812A2 (de) 1991-09-25
DE69116187D1 (de) 1996-02-22
EP0447812B1 (de) 1996-01-10
DE69116187T2 (de) 1996-05-15
EP0447812A3 (en) 1992-07-08
KR910021377A (ko) 1991-12-20
KR0178273B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
LV10860A (lv) Fenilalkilaminu iegusanas panemiens
DE69519469D1 (de) Chinazolin-derivate
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
ES2088903T3 (es) Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
ATE132748T1 (de) Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres
ES2084120T3 (es) Medicamentos para prevenir y tratar enfermedades del aparato circulatorio que contienen compuestos de espiro-3-heteroazolidina.
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
ATE124259T1 (de) Thiazolidine-2,4-dione für die behandlung der hypertonie.
DE3650311D1 (de) Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
KR890009886A (ko) 심기능 부전의 예방 및 치료제
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69313775D1 (de) Mittel zur Verbesserung der peripheren Durchblutung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties